SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurocrine Biosciences (NBIX)
An SI Board Since July 1996
Posts SubjectMarks Bans Symbol
1834 74 0 NBIX
Emcee:  Billy Dunn Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
734"RESEARCH ALERT-Four drug cos started as buy 5/24/2001 12:00:00 PM NEW YOIcebrg-5/24/2001
733Nature 411, 480 - 484 (2001) © Macmillan Publishers Ltd. Leptin activateMiljenko Zuanic-5/23/2001
732Jim, <<Of course endogenous stress related models compared to exogenous pMiljenko Zuanic-5/21/2001
731Miljenko- Concerning the IBD press release from a couple of days ago, I wouldBiotech Jim-5/21/2001
730It was about time that someone from analyst universe rises his/her head from senMiljenko Zuanic-5/21/2001
729Harmon - You can say that again!!!!!!!!!! ijIRWIN JAMES FRANKEL-5/21/2001
728Robbie Stephens Upgrade. robertsonstephens.com Neurocrine Biosciences, Inc. Icebrg-5/21/2001
727wheeeeeeeeeeeeeee!!! (eom)scaram(o)uche-5/21/2001
7267:48AM Neurocrine Biosci (NBIX) 31.44: Robertson Stephens upgrades to STRONG BUYIcebrg-5/21/2001
725<<Treatment with a single oral dose of the CRF1 receptor antagonist producMiljenko Zuanic-5/20/2001
724>>SAN DIEGO, May 20 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: tuck-5/20/2001
723Increases in T-Cell Antigen Responsiveness Precede Clinical Diabetes ----------Miljenko Zuanic-5/14/2001
722Scios awaits hearing on heart drug cbs.marketwatch.com By Barbara C. Costanza,2MAR$-5/14/2001
721Very strait forward presentation by Gary Lyons at DBAB conference. It is a pleaMiljenko Zuanic-5/10/2001
720Thursday May 10, 7:32 am Eastern Time Press Release SOURCE: Neurocrine Biosciescaram(o)uche-5/10/2001
719OT re: SCIO I contacted the company to ask for copy of presentation, or anythinkeokalani'nui-5/2/2001
718OT, SCIO Joe, Very little relevant data in this PR. I did commented early at oMiljenko Zuanic-5/1/2001
717Miljenko--Re: biz.yahoo.com Not much info in this -- Any opinion on this coJOEBT1-5/1/2001
716Message 15737391Miljenko Zuanic-5/1/2001
715April 30 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX - news) todanigel bates-4/30/2001
714Indeed, too much dust for nothing. This guys own less than I do. When I need mMiljenko Zuanic-4/27/2001
713J Neurochem 2001 Apr 15;77(2):550-557 Pharmacological characterization of threMiljenko Zuanic-4/22/2001
712nothing new....... Wednesday April 11, 7:01 am Eastern Time Press Release Pubscaram(o)uche-4/11/2001
711Patent covered old class molecules, nothing new. I am more interested to read anMiljenko Zuanic-4/9/2001
710A whole bunch of -R and -C thingies, with a cycloalkylmethyl here and there.....scaram(o)uche-4/9/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News